These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5091160)

  • 41. Indoleamine metabolism in maturing mouse brain following extended uptake inhibition with citalopram.
    Baker PC; Hoff KM
    Gen Pharmacol; 1987; 18(5):467-71. PubMed ID: 2443420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation.
    Corrodi H; Farnebo LO; Fuxe K; Hamberger B
    Eur J Pharmacol; 1975 Feb; 30(2):172-81. PubMed ID: 1173234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haemorrhage-induced release of noradrenaline, 5-hydroxytryptamine and uric acid in the supraoptic nucleus of the rat, measured by microdialysis.
    Kendrick KM; Leng G
    Brain Res; 1988 Feb; 440(2):402-6. PubMed ID: 2451980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine.
    Carlsson A; Corrodi H; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1969 Mar; 5(4):357-66. PubMed ID: 5786359
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacological aspects of metaldehyde poisoning in mice.
    Homeida AM; Cooke RG
    J Vet Pharmacol Ther; 1982 Mar; 5(1):77-81. PubMed ID: 6178838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uptake and disappearance of 4-methyl-alpha-ethylmetatyramine in relation to its releasing action on 5-hydroxytryptamine in the brain.
    Meisch JJ; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(3):233-42. PubMed ID: 1171382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific inhibition of hypothalamic self-stimulation by selective reuptake blockade of either 5-hydroxytryptamine or noradrenaline.
    Atrens DM; Ungerstedt U; Ljungberg T
    Psychopharmacology (Berl); 1977 Apr; 52(2):177-80. PubMed ID: 407602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's dementia.
    Gottfries CG
    J Neural Transm Suppl; 1990; 30():33-43. PubMed ID: 2202785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of certain drugs on the uptake and release of [3H]noradrenaline in rat whole brain homogenates.
    Pylatuk KL; McNeill JH
    Can J Physiol Pharmacol; 1976 Aug; 54(4):457-68. PubMed ID: 974874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Release of 5-hydroxytryptamine from serotonergic nerve endings by alpha-methyl-meta-tyramine.
    McBride WJ; Aprison MH
    Pharmacol Biochem Behav; 1973; 1(5):587-90. PubMed ID: 4790737
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of tryptophan hydroxylase: neurochemical action of catecholamide seizure-inducing agent.
    Stine S; Kellogg C
    Neurochem Res; 1982 Jan; 7(1):87-98. PubMed ID: 7070582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by alpha-amino acid esters of phenethyl alcohols.
    Lindberg UH; Thorberg SO; Bengtsson S; Renyi AL; Ross SB; Ogren SO
    J Med Chem; 1978 May; 21(5):448-56. PubMed ID: 77901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pyrazole, 4-methylpyrazole, 4-bromopyrazole and 4-iodopyrazole on brain noradrenaline levels of mice and rats.
    MacDonald E
    Acta Pharmacol Toxicol (Copenh); 1976; 39(5):513-24. PubMed ID: 990035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of contents of norepinephrine and 5-hydroxytryptamine in brain--I. Normal and cold exposure.
    Aly MS; Mohamed MI; Rahman TA; Moustafa S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(1):155-8. PubMed ID: 2865055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzoquinolizine derivatives.
    PLETSCHER A; BESENDORF H; GEY KF
    Science; 1959 Mar; 129(3352):844. PubMed ID: 13635024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of dopamine beta-hydroxylase by aquayamycin.
    Nagatsu T; Ayukawa S; Umezawa H
    J Antibiot (Tokyo); 1968 May; 21(5):354-7. PubMed ID: 5726289
    [No Abstract]   [Full Text] [Related]  

  • 57. Brain Monoamine Concentrations as Predictors of Growth Inhibition in Channel Catfish Exposed to Ammonia.
    Atwood HL; Tomasso JR; Ronan PJ; Barton BA; Renner KJ
    J Aquat Anim Health; 2000 Mar; 12(1):69-73. PubMed ID: 28880776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of benzoctamine and chlordiazepoxide on turnover and uptake of 5-hydroxytryptamine in the brain.
    Lippmann W; Pugsley TA
    Br J Pharmacol; 1974 Aug; 51(4):571-5. PubMed ID: 4480288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
    Pawlowski L; Nowak G; Górka Z; Mazela H
    Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities.
    Pugsley T; Lippmann W
    Psychopharmacology (Berl); 1976 May; 47(1):33-41. PubMed ID: 1085452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.